161 related articles for article (PubMed ID: 6196438)
1. Four independent antigenic determinants on the capsid polypeptides of aphthovirus.
Haresnape JM; McCahon D
J Gen Virol; 1983 Nov; 64 (Pt 11)():2345-55. PubMed ID: 6196438
[TBL] [Abstract][Full Text] [Related]
2. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI.
Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D
J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800
[TBL] [Abstract][Full Text] [Related]
3. Location of an immunizing determinant within polypeptide VP1 of type O aphthovirus.
Haresnape JM; King AM; McCahon D
J Gen Virol; 1983 Nov; 64 (Pt 11)():2357-65. PubMed ID: 6196439
[TBL] [Abstract][Full Text] [Related]
4. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1.
Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F
Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.
Xie QC; McCahon D; Crowther JR; Belsham GJ; McCullough KC
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1637-47. PubMed ID: 2438378
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.
Meloen RH; Rowlands DJ; Brown F
J Gen Virol; 1979 Dec; 45(3):761-3. PubMed ID: 94352
[TBL] [Abstract][Full Text] [Related]
7. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.
Bachrach HL; Moore DM; McKercher PD; Polatnick J
J Immunol; 1975 Dec; 115(6):1636-41. PubMed ID: 171309
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
[TBL] [Abstract][Full Text] [Related]
9. A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins.
Meloen RH; Briaire J
J Gen Virol; 1980 Nov; 51(Pt 1):107-16. PubMed ID: 6257830
[TBL] [Abstract][Full Text] [Related]
10. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
Stave JW; Card JL; Morgan DO
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
[TBL] [Abstract][Full Text] [Related]
11. Antigenicity and immunogenicity of poliovirus capsid proteins.
van Wezel AL; van der Marel P; Hazendonk TG; Boer-Bak V; Henneke MA
Dev Biol Stand; 1983; 55():209-15. PubMed ID: 6203795
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
[TBL] [Abstract][Full Text] [Related]
13. Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.
Uhlig H; Haardt F; Dernick R
Arch Virol; 1985; 83(3-4):295-303. PubMed ID: 2578787
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
[TBL] [Abstract][Full Text] [Related]
15. Separation of neutralizing and hemagglutination-inhibiting antibody activities and specificity of antisera to sodium dodecyl sulfate-derived polypeptides of polyoma virions.
Bolen JB; Consigli RA
J Virol; 1980 Apr; 34(1):119-29. PubMed ID: 6154803
[TBL] [Abstract][Full Text] [Related]
16. Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3.
van der Marel P; Hazendonk TG; Henneke MA; van Wezel AL
Vaccine; 1983 Dec; 1(1):17-22. PubMed ID: 6099638
[TBL] [Abstract][Full Text] [Related]
17. Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1.
Rao MG; Butchaiah G; Sen AK
Vet Microbiol; 1994 Mar; 39(1-2):135-43. PubMed ID: 8203119
[TBL] [Abstract][Full Text] [Related]
18. Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats.
Chow M; Baltimore D
Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7518-21. PubMed ID: 6296837
[TBL] [Abstract][Full Text] [Related]
19. Analysis of neutralizing epitopes on foot-and-mouth disease virus.
Pfaff E; Thiel HJ; Beck E; Strohmaier K; Schaller H
J Virol; 1988 Jun; 62(6):2033-40. PubMed ID: 2835507
[TBL] [Abstract][Full Text] [Related]
20. Antigenic and structural relatedness among non-capsid and capsid polypeptides of polioviruses belonging to different serotypes.
Romanova LI; Tolskaya EA; Agol VI
J Gen Virol; 1981 Feb; 52(Pt 2):279-89. PubMed ID: 6169783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
